Burnout is not an individual failure: it’s a systems imbalance, biologically and organizationally, write Tony Martignetti and ...

From left, Jasmina Jankicevic, CMO, Indero; Catherine Tyner, AG Mednet; Claudia Christian, CCO, FHI Clinical Inc.; and Trish Landry, senior vice president of clinical operations, Beaufort CRO Clinical ...

On this week's episode of the Business of Biotech, Bruce Culleton, M.D., CEO at ProKidney, talks about moving from academic research to industry and the role a key mentor played in his career path.

Automation in clinical trials uses technology to handle tasks without human intervention, improving efficiency, reducing errors, and freeing staff to focus on more complex responsibilities. Clinical ...

On this week's episode of the Business of Biotech, Dan Schmitt, President and CEO at Actuate Therapeutics, talks about building a company around elraglusib, a GSK-3β inhibitor for cancer.

Block Clinical Inc. is a clinical trial support company specializing in patient travel logistics, concierge coordination, and automated payments for sites, patients, and suppliers. Powered by a ...

On this week's episode of the Business of Biotech, Sean Ainsworth, CEO and Chairman at Immusoft, talks about transitioning from the research bench to entrepreneurship, his M&A experiences as a biotech ...

A new bipartisan bill, the Biomanufacturing Excellence Act, aims to position the U.S. as a global leader in biopharmaceutical manufacturing. The legislation would create a National Biopharmaceutical ...

Technology alone cannot solve the most pressing challenges in clinical trials. While advanced systems can streamline workflows, enhance data integrity, and accelerate processes, they are only one part ...

Charlotte is stepping into a new era of innovation. Long known as a financial hub, the city is now emerging as a leader in health care advancement with the launch of The Pearl, a groundbreaking ...

Analyses of the biopharmaceutical industry predict that the market for vaccines could grow at a compound annual growth rate of as much as 10.3% between 2013 and 2024 (1). This is faster than growth ...

As a member of my local school board, I've seen firsthand how strongly people can disagree. But here’s what is interesting: When you probe the disagreements, they’re often not about the underlying ...